Blood pressure drugs may increase risk of depression

Image
IANS London
Last Updated : Oct 11 2016 | 2:57 PM IST

Some commonly prescribed blood pressure medications may increase risk of mood disorders such as depression or bipolar disorder, say researchers including one of Indian-origin.

"Mental health is under-recognized in hypertension clinical practice, and the possible impact of antihypertensive drugs on mental health is an area that physicians should be aware of and consider if the treatment of high blood pressure is having a negative impact on their patient's mental health," said Sandosh Padmanabhan, Professor at University of Glasgow in Britain.

In this study, researchers compared four common classes of antihypertensive drugs and risk of mood disorders.

They collected data on 525,046 patients (ages 40-80) from two large secondary care Scottish hospitals.

The researchers selected 144,066 patients being treated for hypertension with either angiotensin antagonists, beta blocker, calcium channel blockers or thiazide diuretics.

They were compared to a group of 111,936 patients not taking any of those drugs.

Researchers followed the patients for five years documenting hospitalisation for mood disorders, such as depression or bipolar disorder.

After more than 90 days on the antihypertensive medications, the study published in the American Heart Association's journal Hypertension, found that there were 299 hospital admissions, predominantly due to major depression, among the patients studied, at an average 2.3 years after patients began antihypertensive treatment.

Patients on beta-blockers and calcium antagonists were at two-fold increased risk of hospital admission for mood disorder, compared to patients on angiotensin antagonists.

Patients on angiotensin antagonists had the lowest risk for hospitalisation with mood disorders compared to patients on other blood pressure meds and patients on no antihypertensive therapy.

Patients taking thiazide diuretics showed the same risk for mood disorders compared to patients taking no antihypertensive drugs, the study found.

--IANS

gb/vt

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 11 2016 | 2:50 PM IST

Next Story